Kura Oncology Inc (KURA)

May 05, 2026

Kura Oncology schedules May 12 webcast for Q1 2026 results - Stock Titan

May 05, 2026

May 05, 2026

Kura Oncology to Report First Quarter 2026 Financial Results - Yahoo Finance

May 05, 2026

May 04, 2026

How The Kura Oncology (KURA) Story Is Evolving After Komzifti Launch And Q4 Reassessment - Yahoo Finance

May 04, 2026

May 04, 2026

Five new Kura hires get stock options for 133,750 shares - Stock Titan

May 04, 2026

May 04, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

May 04, 2026

May 01, 2026

KURA Stock Price, Quote & Chart | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill

May 01, 2026

Apr 30, 2026

Vanguard reports 5.01% stake in Kura Oncology (NASDAQ: KURA) - Stock Titan

Apr 30, 2026

Apr 30, 2026

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance

Apr 30, 2026

Apr 30, 2026

Kura Oncology (KURA) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Moody Aldrich Partners LLC Buys New Position in Kura Oncology, Inc. $KURA - MarketBeat

Apr 29, 2026

Apr 27, 2026

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML - marketscreener.com

Apr 27, 2026

Apr 26, 2026

Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML - BioPharma APAC

Apr 26, 2026

Apr 26, 2026

Kura rises after early-stage trial data for kidney cancer therapy - MSN

Apr 26, 2026

Apr 22, 2026

Kura Oncology shares jump on encouraging kidney cancer trial results - MSN

Apr 22, 2026

Apr 22, 2026

KURA Financials: Income Statement, Balance Sheet & Cash Flow | Kura Oncology Inc - Stock Titan

Apr 22, 2026

Apr 21, 2026

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2025 earnings call transcript - MSN

Apr 21, 2026

Apr 21, 2026

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell CarcinomaSlideshow (NASDAQ:KURA) 2026-04-21 - Seeking Alpha

Apr 21, 2026

Apr 21, 2026

Barclays Sticks to Their Buy Rating for Kura Oncology (KURA) - The Globe and Mail

Apr 21, 2026

Apr 20, 2026

Kura Oncology: Poised For A Lift With Combinations (NASDAQ:KURA) - Seeking Alpha

Apr 20, 2026

Apr 20, 2026

Is Kura Oncology (KURA) stock expanding in volatility (+1.45%) 2026-04-20Community Sell Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 20, 2026

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data - TradingView

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Apr 20, 2026

Apr 20, 2026

Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last? - Yahoo Finance

Apr 20, 2026

Apr 19, 2026

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 19, 2026

Apr 19, 2026

How The Kura Oncology (KURA) Narrative Is Shifting With Komzifti Launch And New Analyst Targets - Yahoo Finance

Apr 19, 2026

Apr 18, 2026

Kura Oncology Advances Kidney Cancer Program With Solid Early-Stage Results - Sahm

Apr 18, 2026

Apr 17, 2026

KURA: Promising Results from Kura Oncology's Trial on ccRCC Trea - GuruFocus

Apr 17, 2026

Apr 17, 2026

LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28 - Moomoo

Apr 17, 2026

Apr 17, 2026

Kura Oncology (NASDAQ:KURA) Stock Price Up 9.7%Time to Buy? - MarketBeat

Apr 17, 2026

Apr 17, 2026

Kura Oncology (KURA) Shows Promising Phase 1 Trial Results for K - GuruFocus

Apr 17, 2026

Apr 17, 2026

Kura Oncology shares jump on positive kidney cancer trial data By Investing.com - Investing.com Canada

Apr 17, 2026

Apr 17, 2026

Kura Oncology Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 17, 2026

Apr 17, 2026

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib - The Manila Times

Apr 17, 2026

Apr 17, 2026

Kura Oncology Announces Promising Preliminary Data on Darlifarnib in Combination with Cabozantinib for ccRCC Patients Previously Treated with Cabozantinib - Quiver Quantitative

Apr 17, 2026

Apr 17, 2026

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients ... - Enidnews.com

Apr 17, 2026

Apr 17, 2026

Kura Oncology Reports Darlifarnib Plus Cabozantinib - GlobeNewswire

Apr 17, 2026

Apr 17, 2026

Kura Oncology, Inc. (KURA) Stock Analysis: A 247% Upside Potential Beckons Investors - DirectorsTalk Interviews

Apr 17, 2026

Apr 17, 2026

Kura Oncology shares jump on positive kidney cancer trial data - Investing.com

Apr 17, 2026

Apr 15, 2026

Kura Oncology (NASDAQ:KURA) Raised to Strong-Buy at Lake Street Capital - MarketBeat

Apr 15, 2026

Apr 15, 2026

Lake Street initiates coverage of Kura Oncology (KURA) with buy recommendation - MSN

Apr 15, 2026